Skip to main content

MoneyWorks4Me

Claris Lifesciences informs about outcome of board meeting

08 May 2017 Evaluate

Claris Lifesciences has informed that the Board of Directors of the Company have approved the sale and transfer of the equity shares of Otsuka Pharmaceutical India (formerly known as Claris Otsuka) held by Claris Lifesciences Limited (CLL) to Otsuka Pharmaceutical Factory, Inc for a consideration of $20 million in its meeting held on May 8, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 359.55
Adani Enterprises 2733.00
Amrapali Industries 33.62
Maxgrow India 182.35
Rashi Peripheral 696.70
View more..